Ticker
LYRACompany Name
LYRA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -43M | -5584.68% | $ 770K |
3/31/2025 | $ -56.59M | -4775.27% | $ 1.19M |
12/31/2024 | $ -72.35M | -4716.36% | $ 1.53M |
9/30/2024 | $ -80.9M | -5499.66% | $ 1.47M |
6/30/2024 | $ -78.88M | -4334.29% | $ 1.82M |
3/31/2024 | $ -73.06M | -4348.81% | $ 1.68M |
12/31/2023 | $ -64.35M | -4130.36% | $ 1.56M |
9/30/2023 | $ -56.7M | -3984.4% | $ 1.42M |
6/30/2023 | $ -53.31M | -4306.54% | $ 1.24M |
3/31/2023 | $ -47.45M | -3635.71% | $ 1.3M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Revenues
(=) FCF %
FCF % for LYRA THERAPEUTICS INC is calculated as follows: FCF [ $ -22.92M ] / Revenues [ $ 0 ]
(=) FCF % [ 0% ]
Minimum
Sep 30, 2021
Maximum
Mar 31, 2022
Average
Median
filtered constituents | 3.18K |
---|---|
min | -58.23% |
max | 68.19% |
average | 7.87% |
median | 7.4% |
std | 19.48% |